Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C

Glioblastoma (GBM) is a lethal cancer with limited therapeutic options. Dendritic cell (DC)-based cancer vaccines provide a promising approach for GBM treatment. Clinical studies suggest that other immunotherapeutic agents may be combined with DC vaccines to further enhance antitumor activity. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ping, Li, Shi-You, Ding, Jin, Fei, Zhou, Sun, Sheng-Nan, Zheng, Zhao-Hui, Wei, Ding, Jiang, Jun, Miao, Jin-Lin, Li, San-Zhong, Luo, Xing, Zhang, Kui, Wang, Bin, Zhang, Kun, Pu, Su, Wang, Qian-Ting, Zhang, Xin-Yue, Wen, Gao-Liu, Liu, Jun O., August, John Thomas, Bian, Huijie, Chen, Zhi-Nan, He, You-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Xi'an Jiaotong University 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334272/
https://www.ncbi.nlm.nih.gov/pubmed/37440907
http://dx.doi.org/10.1016/j.jpha.2023.04.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334272/
https://www.ncbi.nlm.nih.gov/pubmed/37440907
http://dx.doi.org/10.1016/j.jpha.2023.04.012

Ejemplares similares